R&D at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's R&D?
- Tectonic Therapeutics (TECX) reported R&D of $20.87M in Q1 2026.
- How has Tectonic Therapeutics's R&D changed year-over-year?
- Tectonic Therapeutics's R&D increased by 60.1% year-over-year, from $13.04M to $20.87M.
- What is the long-term trend for Tectonic Therapeutics's R&D?
- Over 4 years (2021 to 2025), Tectonic Therapeutics's R&D has grown at a -6.5% compound annual growth rate (CAGR), from $83.11M to $63.49M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.